Pharmacogenetics of asthma

Current Opinion in Pharmacology
Rodolfo M Pascual, Eugene R Bleecker

Abstract

Current asthma treatments are effective for most but not all patients. Asthma is classified as a complex genetic disease with its pathogenesis and expression (severity) determined by the interaction of many genes and environmental factors. Asthma is characterized by its heterogeneity in terms of its clinical and inflammatory phenotypes and their responses to therapy. This disease heterogeneity likely has played a role in variable results from clinical trials that evaluate specific inhibitors of inflammatory mediators ('biologics') in asthma. Moreover, although existing treatments are effective and safe in most asthma patients they may be less effective or potentially harmful in others. In addition, if an individual with asthma is less responsive to standard therapies such as corticosteroids because of specific pharmacogenetic interactions then that patient with asthma will be classified as having more severe or difficult-to-treat asthma. Pharmacogenetic approaches hold the promise of matching individualized treatments to specific genotypes in a way that minimizes side effects while improving therapeutic outcomes.

Citations

May 18, 2012·TheScientificWorldJournal·Steven Maranz
Oct 18, 2013·The Journal of Allergy and Clinical Immunology·Louise HoskingDeborah Meyers
Aug 30, 2012·Clinics in Chest Medicine·Rebecca E SlagerEugene R Bleecker
Dec 14, 2011·The Journal of Allergy and Clinical Immunology·Harald RenzDirk Haller
Feb 9, 2017·Pharmacology & Therapeutics·Diana BehrensIduna Fichtner
Aug 11, 2011·International Archives of Allergy and Immunology·Kenya KohyamaMotohiro Kurosawa
Mar 30, 2012·Expert Review of Respiratory Medicine·Michael Portelli, Ian Sayers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.